These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1624831)

  • 1. [The study of pathogenic mechanisms of chronic Pseudomonas aeruginosa lung infections by mucoid strains].
    Ohno A; Miyazaki S; Tateda K; Kaneko Y; Huruya N; Tsuji A; Yamaguchi K; Goto S
    Kansenshogaku Zasshi; 1992 Mar; 66(3):407-15. PubMed ID: 1624831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
    Song Z; Wu H; Ciofu O; Kong KF; Høiby N; Rygaard J; Kharazmi A; Mathee K
    J Med Microbiol; 2003 Sep; 52(Pt 9):731-740. PubMed ID: 12909647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the biological characteristics of mucoid and non-mucoid Pseudomonas aeruginosa strains isolated from chronic respiratory infections.
    Meitert E; Sima F; Savulian C; Chersulick E; Sălăgeanu A
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):193-207. PubMed ID: 2519631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
    Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
    APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
    Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
    Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
    J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs.
    Blackwood LL; Pennington JE
    Infect Immun; 1981 May; 32(2):443-8. PubMed ID: 6788696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysaccharides serve as scaffold of biofilms formed by mucoid Pseudomonas aeruginosa.
    Yang L; Hengzhuang W; Wu H; Damkiaer S; Jochumsen N; Song Z; Givskov M; Høiby N; Molin S
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):366-76. PubMed ID: 22309122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
    Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
    J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
    Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Høiby N; Espersen F; Koch C
    Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
    van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis.
    Deretic V; Schurr MJ; Yu H
    Trends Microbiol; 1995 Sep; 3(9):351-6. PubMed ID: 8520888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis.
    Moser C; Van Gennip M; Bjarnsholt T; Jensen PØ; Lee B; Hougen HP; Calum H; Ciofu O; Givskov M; Molin S; Høiby N
    APMIS; 2009 Feb; 117(2):95-107. PubMed ID: 19239431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.